.. Réalisation, 81 10 PCR en émulsion (emPCR) 82 10.1. Préparation des réactifs et de la pré-émulsion, Récupération des billes, p.84

V. Aimanianda and J. Latgé, Problems and hopes in the development of drugs targeting the fungal cell wall, Expert Review of Anti-infective Therapy, vol.8, issue.4, pp.359-64, 2010.
DOI : 10.1586/eri.10.13

S. Silva, M. Negri, M. Henriques, R. Oliveira, D. Williams et al., : biology, epidemiology, pathogenicity and antifungal resistance, FEMS Microbiology Reviews, vol.36, issue.2, pp.288-305, 2012.
DOI : 10.1111/j.1574-6976.2011.00278.x

G. Brown, D. Denning, N. Gow, S. Levitz, M. Netea et al., Hidden Killers: Human Fungal Infections, Science Translational Medicine, vol.4, issue.165, pp.165-178, 2012.
DOI : 10.1126/scitranslmed.3004404

R. Bennett, Coming of Age???Sexual Reproduction in Candida Species, PLoS Pathogens, vol.19, issue.12, p.1001155, 2010.
DOI : 10.1371/journal.ppat.1001155.g002

G. Butler, M. Rasmussen, M. Lin, M. Santos, S. Sakthikumar et al., Evolution of pathogenicity and sexual reproduction in eight Candida genomes, Nature, vol.440, issue.7247, pp.657-62, 2009.
DOI : 10.1038/nature08064

T. Jones, N. Federspiel, H. Chibana, J. Dungan, S. Kalman et al., The diploid genome sequence of Candida albicans, Proceedings of the National Academy of Sciences, vol.101, issue.19, pp.7329-7363, 2004.
DOI : 10.1073/pnas.0401648101

L. Kruglyak and D. Nickerson, Variation is the spice of life, Nature Genetics, vol.27, issue.3, pp.234-240, 2001.
DOI : 10.1038/85776

M. Logue, S. Wong, K. Wolfe, and G. Butler, A Genome Sequence Survey Shows that the Pathogenic Yeast Candida parapsilosis Has a Defective MTLa1 Allele at Its Mating Type Locus, Eukaryotic Cell, vol.4, issue.6, pp.1009-1026, 2005.
DOI : 10.1128/EC.4.6.1009-1017.2005

P. Eggimann, J. Garbino, and D. Pittet, Epidemiology of Candida species infections in critically ill non-immunosuppressed patients, The Lancet Infectious Diseases, vol.3, issue.11, pp.685-702, 2003.
DOI : 10.1016/S1473-3099(03)00801-6

D. Diekema, S. Arbefeville, L. Boyken, J. Kroeger, and M. Pfaller, The changing epidemiology of healthcare-associated candidemia over three decades, Diagnostic Microbiology and Infectious Disease, vol.73, issue.1, p.2012
DOI : 10.1016/j.diagmicrobio.2012.02.001

H. Wisplinghoff, T. Bischoff, S. Tallent, H. Seifert, R. Wenzel et al., Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study, Clinical Infectious Diseases, vol.39, issue.3, pp.309-326, 2004.
DOI : 10.1086/421946

C. Lass-flörl, The changing face of epidemiology of invasive fungal disease in Europe, Mycoses, vol.11, issue.3, pp.197-205, 2009.
DOI : 10.1111/j.1439-0507.2009.01691.x

D. Toubas, Epidémiologie des candidoses invasives. Rev. Française Lab, pp.27-36, 2013.

M. Lionakis and M. Netea, Candida and Host Determinants of Susceptibility to Invasive Candidiasis, PLoS Pathogens, vol.54, issue.1, p.1003079
DOI : 10.1371/journal.ppat.1003079.s001

N. Gow, F. Van-de-veerdonk, A. Brown, and M. Netea, Candida albicans morphogenesis and host defence: discriminating invasion from colonization, Nature Reviews Microbiology, vol.139, p.2012
DOI : 10.1038/nrmicro2711

N. Gow and B. Hube, Importance of the Candida albicans cell wall during commensalism and infection, Current Opinion in Microbiology, vol.15, issue.4, pp.406-418, 2012.
DOI : 10.1016/j.mib.2012.04.005

M. Pfaller and D. Diekema, Epidemiology of Invasive Mycoses in North America, Critical Reviews in Microbiology, vol.29, issue.6, pp.1-53, 2010.
DOI : 10.1128/JCM.41.11.5233-5235.2003

M. Arendrup, Epidemiology of invasive candidiasis, Current Opinion in Critical Care, vol.16, issue.5, 2010.
DOI : 10.1097/MCC.0b013e32833e84d2

D. Toro, M. Torres, M. Maite, R. Aznar, and J. , Characterization of Candida parapsilosis complex isolates, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, 2011.

E. Cantón, J. Pemán, G. Quindós, E. Eraso, I. Miranda-zapico et al., Prospective Multicenter Study of the Epidemiology, Molecular Identification, and Antifungal Susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Isolated from Patients with Candidemia, Antimicrobial Agents and Chemotherapy, vol.55, issue.12, pp.5590-5596, 2011.
DOI : 10.1128/AAC.00466-11

C. Orsi, B. Colombari, and E. Blasi, Candida metapsilosis as the least virulent member of the " C. parapsilosis " complex, Med. Mycol. Off. Publ. Int. Soc. Hum. Anim. Mycol, 2010.

A. Bertini, D. Bernardis, F. Hensgens, L. Sandini, S. Senesi et al., Comparison of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis adhesive properties and pathogenicity, International Journal of Medical Microbiology, vol.303, issue.2, pp.98-103, 2013.
DOI : 10.1016/j.ijmm.2012.12.006

A. Silva, I. Miranda, C. Lisboa, C. Pina-vaz, and A. Rodrigues, Prevalence, Distribution, and Antifungal Susceptibility Profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a Tertiary Care Hospital, Journal of Clinical Microbiology, vol.47, issue.8, pp.2392-2399, 2009.
DOI : 10.1128/JCM.02379-08

M. Pfaller, G. Moet, S. Messer, R. Jones, and M. Castanheira, Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009), Journal of Clinical Microbiology, vol.49, issue.1, pp.396-405, 2008.
DOI : 10.1128/JCM.01398-10

D. Kett, E. Azoulay, P. Echeverria, and J. Vincent, Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study*, Critical Care Medicine, vol.39, issue.4, pp.665-70, 2011.
DOI : 10.1097/CCM.0b013e318206c1ca

URL : https://hal.archives-ouvertes.fr/hal-00739819

M. Pfaller, M. Castanheira, S. Messer, G. Moet, and R. Jones, Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008???2009), Diagnostic Microbiology and Infectious Disease, vol.68, issue.3, pp.278-83, 2008.
DOI : 10.1016/j.diagmicrobio.2010.06.015

C. Moran, C. Grussemeyer, J. Spalding, D. Benjamin, . Jr et al., CANDIDA ALBICANS AND NON-ALBICANS BLOODSTREAM INFECTIONS IN ADULT AND PEDIATRIC PATIENTS, The Pediatric Infectious Disease Journal, vol.28, issue.5, pp.433-438, 2009.
DOI : 10.1097/INF.0b013e3181920ffd

M. Bougnoux, G. Kac, P. Aegerter, C. Enfert, J. Fagon et al., Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome, Intensive Care Medicine, vol.36, issue.2, pp.292-301, 2008.
DOI : 10.1007/s00134-007-0865-y

O. Leroy, J. Gangneux, P. Montravers, J. Mira, F. Gouin et al., Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France, Crit. Care Med, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00676899

C. Blyth, S. Chen, M. Slavin, C. Serena, Q. Nguyen et al., Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients, PEDIATRICS, vol.123, issue.5, pp.1360-1368, 2009.
DOI : 10.1542/peds.2008-2055

A. Holley, J. Dulhunty, S. Blot, . J. Lipman, S. Lobo et al., Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units, International Journal of Antimicrobial Agents, vol.33, issue.6, pp.554-555, 2009.
DOI : 10.1016/j.ijantimicag.2008.10.035

A. Tragiannidis, C. Tsoulas, K. Kerl, and A. Groll, Invasive candidiasis: update on current pharmacotherapy options and future perspectives, Expert Opinion on Pharmacotherapy, vol.10, issue.2, p.2013
DOI : 10.1007/s100960050185

D. Marriott, E. Playford, S. Chen, M. Slavin, Q. Nguyen et al., Determinants of mortality in non-neutropenic ICU patients with candidaemia, Critical Care, vol.13, issue.4, p.115, 2009.
DOI : 10.1097/00005792-200305000-00005

M. Arendrup, S. Sulim, A. Holm, L. Nielsen, S. Nielsen et al., Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia, Journal of Clinical Microbiology, vol.49, issue.9, 2011.
DOI : 10.1128/JCM.00179-11

P. Vandeputte, S. Ferrari, A. Coste, . Fc, A. Brown et al., Antifungal resistance and new strategies to control fungal infections Antifungal agents: mechanisms of action, Int. J. Microbiol. Trends Microbiol, vol.201211, issue.376, pp.713687272-713687281, 2003.

D. Sanglard, A. Coste, and S. Ferrari, Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. Fems Yeast Res, pp.1029-50, 2009.

A. Coste, A. Selmecki, A. Forche, D. Diogo, M. Bougnoux et al., Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates, Eukaryotic Cell, vol.6, issue.10, 2007.
DOI : 10.1128/EC.00151-07

A. Coste, V. Turner, F. Ischer, J. Morschhäuser, A. Forche et al., A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans, Genetics, vol.172, issue.4, 2006.
DOI : 10.1534/genetics.105.054767

R. Torelli, B. Posteraro, S. Ferrari, L. Sorda, M. Fadda et al., The ATP-binding cassette transporter???encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata, Molecular Microbiology, vol.43, issue.1, pp.186-201, 2008.
DOI : 10.1016/j.gene.2006.09.029

S. Ferrari, F. Ischer, D. Calabrese, B. Posteraro, M. Sanguinetti et al., Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence, PLoS Pathogens, vol.1, issue.1, p.1000268, 2009.
DOI : 10.1371/journal.ppat.1000268.s008

F. Morio, C. Loge, B. Besse, C. Hennequin, L. Pape et al., Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature, Diagnostic Microbiology and Infectious Disease, vol.66, issue.4, 2010.
DOI : 10.1016/j.diagmicrobio.2009.11.006

S. Flowers, K. Barker, E. Berkow, G. Toner, S. Chadwick et al., Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans, Eukaryotic Cell, vol.11, issue.10, pp.1289-99, 2012.
DOI : 10.1128/EC.00215-12

D. Sanglard and F. Odds, Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences, The Lancet Infectious Diseases, vol.2, issue.2, pp.73-85, 2002.
DOI : 10.1016/S1473-3099(02)00181-0

F. Morio, F. Pagniez, C. Lacroix, M. Miegeville, L. Pape et al., Amino acid substitutions in the Candida albicans sterol ??5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence, Journal of Antimicrobial Chemotherapy, vol.67, issue.9, pp.2131-2139, 2012.
DOI : 10.1093/jac/dks186

S. Poláková, C. Blume, J. Zárate, M. Mentel, D. Jørck-ramberg et al., Formation of new chromosomes as a virulence mechanism in yeast Candida glabrata, Proceedings of the National Academy of Sciences, vol.106, issue.8, pp.2688-93, 2009.
DOI : 10.1073/pnas.0809793106

D. Perlin, Current perspectives on echinocandin class drugs. Future Microbiol, 2011.

S. Katiyar, A. Alastruey-izquierdo, K. Healey, M. Johnson, D. Perlin et al., Fks1 and Fks2 Are Functionally Redundant but Differentially Regulated in Candida glabrata: Implications for Echinocandin Resistance, Antimicrobial Agents and Chemotherapy, vol.56, issue.12, pp.6304-6313, 2012.
DOI : 10.1128/AAC.00813-12

L. Walker, N. Gow, and C. Munro, Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin, Antimicrobial Agents and Chemotherapy, vol.57, issue.1, pp.146-54
DOI : 10.1128/AAC.01486-12

L. Walker, N. Gow, and C. Munro, Fungal echinocandin resistance, Fungal Genetics and Biology, vol.47, issue.2, pp.117-143, 2010.
DOI : 10.1016/j.fgb.2009.09.003

C. Munro, Fungal echinocandin resistance, F1000 Biology Reports, vol.2, p.66, 2010.
DOI : 10.3410/B2-66

D. Perlin, Targeting glucan synthase: the next generation. Fifth FEBS Advanced Lecture Course, 2013.

C. Munro, Chitin and Glucan, the Yin and Yang of the Fungal Cell Wall, Implications for Antifungal Drug Discovery and Therapy, Adv. Appl. Microbiol, vol.83, pp.145-72, 2013.
DOI : 10.1016/B978-0-12-407678-5.00004-0

K. Lee, D. Maccallum, M. Jacobsen, L. Walker, F. Odds et al., Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo, Antimicrobial Agents and Chemotherapy, vol.56, issue.1, pp.208-225
DOI : 10.1128/AAC.00683-11

D. Ellis, Amphotericin B: spectrum and resistance, Journal of Antimicrobial Chemotherapy, vol.49, issue.suppl 1, pp.7-10, 2002.
DOI : 10.1093/jac/49.suppl_1.7

P. Pappas, C. Kauffman, D. Andes, D. Benjamin, T. Calandra et al., Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.48, issue.5, pp.503-538, 2009.
DOI : 10.1086/596757

F. Chapeland-leclerc, C. Hennequin, N. Papon, T. Noël, A. Girard et al., Acquisition of Flucytosine, Azole, and Caspofungin Resistance in Candida glabrata Bloodstream Isolates Serially Obtained from a Hematopoietic Stem Cell Transplant Recipient, Antimicrobial Agents and Chemotherapy, vol.54, issue.3, pp.1360-1362, 2010.
DOI : 10.1128/AAC.01138-09

URL : https://hal.archives-ouvertes.fr/hal-00594730

S. Singh-babak, T. Babak, S. Diezmann, J. Hill, J. Xie et al., Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata, PLoS Pathogens, vol.18, issue.Pt 6, p.1002718, 2012.
DOI : 10.1371/journal.ppat.1002718.s007

M. Pfaller, M. Castanheira, S. Lockhart, A. Ahlquist, S. Messer et al., Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata, Journal of Clinical Microbiology, vol.50, issue.4, pp.1199-203
DOI : 10.1128/JCM.06112-11

M. Pfaller, G. Moet, S. Messer, R. Jones, and M. Castanheira, Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008.

B. Alexander, M. Johnson, C. Pfeiffer, C. Jiménez-ortigosa, J. Catania et al., Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations, Clinical Infectious Diseases, vol.56, issue.12, pp.1724-1756, 2013.
DOI : 10.1093/cid/cit136

C. Renaudat, K. Sitbon, M. Desnos-ollivier, A. Fontanet, S. Bretagne et al., Candidémies en Île-de-France : données de l'Observatoire des levures, 2002.

R. Shields, M. Nguyen, E. Press, A. Kwa, S. Cheng et al., The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata, Antimicrobial Agents and Chemotherapy, vol.56, issue.9, pp.4862-4871, 2012.
DOI : 10.1128/AAC.00027-12

A. Cleveland, M. Farley, L. Harrison, B. Stein, R. Hollick et al., Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011, Clinical Infectious Diseases, vol.55, issue.10, pp.1352-61, 2008.
DOI : 10.1093/cid/cis697

. Invs, Dernières données et tendances sur la résistance aux anti-infectieux -Candida spp, 2013.

C. Pfeiffer, G. Garcia-effron, A. Zaas, J. Perfect, D. Perlin et al., Breakthrough Invasive Candidiasis in Patients on Micafungin, Journal of Clinical Microbiology, vol.48, issue.7, pp.2373-80, 2010.
DOI : 10.1128/JCM.02390-09

N. Kabbara, C. Lacroix, P. De-latour, R. Socié, G. Ghannoum et al., Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy, Haematologica, vol.93, issue.4, 2008.
DOI : 10.3324/haematol.11149

M. Baixench, N. Aoun, M. Desnos-ollivier, D. Garcia-hermoso, S. Bretagne et al., Acquired resistance to echinocandins in Candida albicans: case report and review, Journal of Antimicrobial Chemotherapy, vol.59, issue.6, pp.1076-83, 2007.
DOI : 10.1093/jac/dkm095

J. Turnidge, G. Kahlmeter, and G. Kronvall, Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values, Clinical Microbiology and Infection, vol.12, issue.5, pp.418-443, 2006.
DOI : 10.1111/j.1469-0691.2006.01377.x

M. Pfaller, D. Diekema, D. Andes, M. Arendrup, S. Brown et al., Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria, Drug Resistance Updates, vol.14, issue.3, pp.164-76, 2011.
DOI : 10.1016/j.drup.2011.01.004

J. Turnidge and D. Paterson, Setting and Revising Antibacterial Susceptibility Breakpoints, Clinical Microbiology Reviews, vol.20, issue.3, pp.391-408, 2007.
DOI : 10.1128/CMR.00047-06

M. Pfaller, Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment, The American Journal of Medicine, vol.125, issue.1, pp.3-13
DOI : 10.1016/j.amjmed.2011.11.001

M. Pfaller and D. Diekema, Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012, Journal of Clinical Microbiology, vol.50, issue.9, pp.2846-56, 2012.
DOI : 10.1128/JCM.00937-12

R. Shields, M. Nguyen, E. Press, C. Updike, and C. Clancy, Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure, Antimicrobial Agents and Chemotherapy, vol.57, issue.8, pp.3528-3563, 2013.
DOI : 10.1128/AAC.00136-13

M. Pfaller, D. Diekema, M. Ghannoum, J. Rex, B. Alexander et al., Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods, Journal of Clinical Microbiology, vol.47, issue.10, pp.3142-3148, 2009.
DOI : 10.1128/JCM.00940-09

M. Arendrup and M. Pfaller, Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints, Antimicrobial Agents and Chemotherapy, vol.56, issue.7, pp.3965-3973
DOI : 10.1128/AAC.00355-12

A. Maxam and W. Gilbert, A new method for sequencing DNA., Proceedings of the National Academy of Sciences, vol.74, issue.2, 1977.
DOI : 10.1073/pnas.74.2.560

F. Sanger, S. Nicklen, and A. Coulson, DNA sequencing with chain-terminating inhibitors, Proc. Natl
DOI : 10.1073/pnas.74.12.5463

L. Smith, J. Sanders, R. Kaiser, P. Hughes, C. Dodd et al., Fluorescence detection in automated DNA sequence analysis, Nature, vol.13, issue.6071, pp.674-683, 1986.
DOI : 10.1038/321674a0

J. Shendure and J. H. , Next-generation DNA sequencing, Nature Biotechnology, vol.105, issue.10, pp.1135-1180, 2008.
DOI : 10.1038/nbt1486

P. Nyrén, The History of Pyrosequencing??, Methods Mol. Biol. Clifton Nj, vol.373, pp.1-14, 2007.
DOI : 10.1007/978-1-4939-2715-9_1

Z. Su, B. Ning, H. Fang, H. Hong, R. Perkins et al., Next-generation sequencing and its applications in molecular diagnostics, Expert Rev. Mol. Diagn, vol.11, issue.3, pp.333-376, 2011.

N. Loman, R. Misra, T. Dallman, C. Constantinidou, S. Gharbia et al., Performance comparison of benchtop high-throughput sequencing platforms, Nat. Biotechnol, p.2012

S. Jünemann, F. Sedlazeck, K. Prior, A. Albersmeier, U. John et al., Updating benchtop sequencing performance comparison, Nature Biotechnology, vol.9, issue.4, pp.294-300
DOI : 10.1186/1471-2164-13-341

S. Mcginn and I. Gut, DNA sequencing ??? spanning the generations, New Biotechnology, vol.30, issue.4, pp.366-72, 2013.
DOI : 10.1016/j.nbt.2012.11.012

R. Ke, M. Mignardi, A. Pacureanu, J. Svedlund, J. Botling et al., In situ sequencing for RNA analysis in preserved tissue and cells, Nature Methods, vol.456, issue.9, 2013.
DOI : 10.1038/nmeth.2563

T. Kenri, A. Horino, M. Matsui, Y. Sasaki, S. Suzuki et al., Complete Genome Sequence of Mycoplasma pneumoniae Type 2a Strain 309, Isolated in Japan, Journal of Bacteriology, vol.194, issue.5, p.2012
DOI : 10.1128/JB.06553-11

O. Cissé, M. Pagni, and P. Hauser, De Novo Assembly of the Pneumocystis jirovecii Genome from a Single Bronchoalveolar Lavage Fluid Specimen from a Patient, mBio, vol.4, issue.1, pp.428-00412, 2012.
DOI : 10.1128/mBio.00428-12

D. Dudley, E. Chin, B. Bimber, S. Sanabani, L. Tarosso et al., Low-Cost Ultra-Wide Genotyping Using Roche/454 Pyrosequencing for Surveillance of HIV Drug Resistance, PLoS ONE, vol.26, issue.2, p.36494, 2012.
DOI : 10.1371/journal.pone.0036494.s003

H. Fleury, P. Bellecave, P. Recordon-pinson, J. Papuchon, M. Vandenhende et al., Detection of Low-Frequency HIV-1 RT Drug Resistance Mutations by Ultra-Deep Sequencing in Naïve HIV-1 Infected individuals, Aids Res. Hum. Retroviruses, 2013.

S. Larrat, Did Ultra-Deep pyrosequencing of the NS3 region can help to predict sustained virological response to pegylated interferon-ribavirine-anti-protease triple therapy in previously treated chronic HCV genotype 1 infection?, 2013.

M. Lauck, M. Alvarado-mora, E. Becker, D. Bhattacharya, R. Striker et al., Analysis of Hepatitis C Virus Intrahost Diversity across the Coding Region by Ultradeep Pyrosequencing, Journal of Virology, vol.86, issue.7
DOI : 10.1128/JVI.06627-11

M. Yasugi, S. Nakamura, T. Daidoji, N. Kawashita, R. Ramadhany et al., Frequency of D222G and Q223R Hemagglutinin Mutants of Pandemic (H1N1) 2009 Influenza Virus in Japan between 2009 and 2010, PLoS ONE, vol.4, issue.2, p.30946, 2009.
DOI : 10.1371/journal.pone.0030946.s007

S. Monira, S. Nakamura, K. Gotoh, K. Izutsu, H. Watanabe et al., Gut Microbiota of Healthy and Malnourished Children in Bangladesh, Frontiers in Microbiology, vol.2, p.228, 2011.
DOI : 10.3389/fmicb.2011.00228

L. Delhaes, Que peut-on attendre du microbiome dans la mucoviscidose ? Congrès de la Société Française de Mycologie Médicale et de la Société Française de Parasitologie -Rennes, 2012.

L. Delhaes, S. Monchy, E. Fréalle, C. Hubans, J. Salleron et al., The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community???Implications for Therapeutic Management, PLoS ONE, vol.8, issue.Database issue, p.36313, 2012.
DOI : 10.1371/journal.pone.0036313.s009

URL : https://hal.archives-ouvertes.fr/hal-00806782

F. Botterel, Colonisation bactérienne et fongique du tractus respiratoire des patients atteints de mucoviscidose : Comparaison de la culture avec les techniques de RFLP, clonage et séquençage à haut débit. RICAI (Réunion Interdisciplinaire de Chimiothérapie Anti-infectieuse), 2012.

L. Delhaes, Caractérisation de l'écosystème broncho-pulmonaire chez les patients atteints de mucoviscidose : structure et dynamique du microbiote pulmonaire dans l'évolution clinique de la mucoviscidose, RICAI

L. Delhaes, Recent updates in fungal respiratory infections in cystic fibrosis ? What can we learn from studying fungal and bacterial microbiota? ISHAM (International Society for Human and Animal Mycology, 2012.

L. Delhaes and F. Botterel, Que peut-on attendre du microbiote pulmonaire notamment du mycobiome dans les pathologies pulmonaires chroniques telles que la mucoviscidose ? Congrès de la Société Française de Mycologie Médicale, 2013.

D. Daigle, B. Simen, and P. Pochart, High-Throughput Sequencing of PCR Products Tagged with Universal Primers Using 454 Life Sciences Systems, Curr. Protoc. Mol. Biol. Ed. Frederick M Ausubel Al, vol.55, issue.7, pp.7-12, 2011.
DOI : 10.1002/0471142727.mb0705s96

D. Sanglard, K. Kuchler, F. Ischer, J. Pagani, M. Monod et al., Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters, Antimicrobial Agents and Chemotherapy, vol.39, issue.11, pp.2378-86, 1995.
DOI : 10.1128/AAC.39.11.2378

D. Maccallum, A. Coste, F. Ischer, M. Jacobsen, F. Odds et al., Genetic Dissection of Azole Resistance Mechanisms in Candida albicans and Their Validation in a Mouse Model of Disseminated Infection, Antimicrobial Agents and Chemotherapy, vol.54, issue.4, pp.1476-83, 2010.
DOI : 10.1128/AAC.01645-09

D. Maubon, M. Dubosson, C. Chiquet, H. Yera, M. Brenier-pinchart et al., Keratitis Diagnosis and Quality Samples Control, Investigative Opthalmology & Visual Science, vol.53, issue.6, pp.2866-72, 2012.
DOI : 10.1167/iovs.11-8587

URL : https://hal.archives-ouvertes.fr/hal-00817999

N. Wiederhold, J. Grabinski, G. Garcia-effron, D. Perlin, and S. Lee, Pyrosequencing To Detect Mutations in FKS1 That Confer Reduced Echinocandin Susceptibility in Candida albicans, Antimicrobial Agents and Chemotherapy, vol.52, issue.11, pp.4145-4153, 2008.
DOI : 10.1128/AAC.00959-08

R. Novais and Y. Thorstenson, The evolution of Pyrosequencing?? for microbiology: From genes to genomes, Journal of Microbiological Methods, vol.86, issue.1, pp.1-7, 2011.
DOI : 10.1016/j.mimet.2011.04.006

R. Shapiro, N. Robbins, and L. Cowen, Regulatory Circuitry Governing Fungal Development, Drug Resistance, and Disease, Microbiology and Molecular Biology Reviews, vol.75, issue.2, pp.213-67, 2011.
DOI : 10.1128/MMBR.00045-10

G. Garcia-effron, S. Park, and D. Perlin, Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints, Antimicrobial Agents and Chemotherapy, vol.53, issue.1
DOI : 10.1128/AAC.01162-08

S. Balashov, S. Park, and D. Perlin, Assessing Resistance to the Echinocandin Antifungal Drug Caspofungin in Candida albicans by Profiling Mutations in FKS1, Antimicrobial Agents and Chemotherapy, vol.50, issue.6, pp.2058-63, 2006.
DOI : 10.1128/AAC.01653-05

G. Garcia-effron, S. Lee, S. Park, J. Cleary, and D. Perlin, Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-??-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint, Antimicrobial Agents and Chemotherapy, vol.53, issue.9, pp.3690-3699, 2009.
DOI : 10.1128/AAC.00443-09

A. Zimbeck, N. Iqbal, A. Ahlquist, M. Farley, L. Harrison et al., FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance, Antimicrobial Agents and Chemotherapy, vol.54, issue.12, pp.5042-5049, 2010.
DOI : 10.1128/AAC.00836-10

G. Garcia-effron, D. Chua, J. Tomada, J. Dipersio, D. Perlin et al., Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species, Antimicrobial Agents and Chemotherapy, vol.54, issue.5, pp.2225-2232, 2010.
DOI : 10.1128/AAC.00998-09

M. Durán-valle, S. Gago, A. Gómez-lópez, M. Cuenca-estrella, L. Díez-canseco et al., Recurrent Episodes of Candidemia Due to Candida glabrata with a Mutation in Hot Spot 1 of the FKS2 Gene Developed after Prolonged Therapy with Caspofungin, Antimicrobial Agents and Chemotherapy, vol.56, issue.6, pp.3417-3426, 2012.
DOI : 10.1128/AAC.06100-11

S. Costa-de-oliveira, M. Miranda, I. Silva, R. Pinto, E. Silva et al., FKS2 Mutations Associated with Decreased Echinocandin Susceptibility of Candida glabrata following Anidulafungin Therapy, Antimicrobial Agents and Chemotherapy, vol.55, issue.3, pp.1312-1316, 2011.
DOI : 10.1128/AAC.00589-10

J. Vermitsky, K. Earhart, W. Smith, R. Homayouni, T. Edlind et al., Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies, Molecular Microbiology, vol.28, issue.3, pp.704-726, 2006.
DOI : 10.1128/AAC.48.10.3773-3781.2004

T. Edlind, K. Henry, J. Vermitsky, M. Edlind, S. Raj et al., Promoter-dependent disruption of genes: simple, rapid, and specific PCR-based method with application to three different yeast, Current Genetics, vol.16, issue.2, pp.117-142, 2005.
DOI : 10.1007/s00294-005-0008-3

P. Vandeputte, G. Tronchin, F. Rocher, G. Renier, T. Bergès et al., Hypersusceptibility to Azole Antifungals in a Clinical Isolate of Candida glabrata with Reduced Aerobic Growth, Antimicrobial Agents and Chemotherapy, vol.53, issue.7, pp.3034-3075, 2009.
DOI : 10.1128/AAC.01384-08

URL : https://hal.archives-ouvertes.fr/hal-00441049

A. Thompson, S. Locarnini, and M. Beard, Resistance to anti-HCV protease inhibitors, Current Opinion in Virology, vol.1, issue.6, pp.599-606, 2011.
DOI : 10.1016/j.coviro.2011.10.001

N. Forestier, H. Reesink, C. Weegink, L. Mcnair, T. Kieffer et al., Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C, Hepatology, vol.127, issue.3, pp.640-648, 2007.
DOI : 10.1002/hep.21774

F. Morio, G. Aubin, I. Danner-boucher, A. Haloun, E. Sacchetto et al., High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis, Journal of Antimicrobial Chemotherapy, vol.67, issue.8, p.2012
DOI : 10.1093/jac/dks160

E. Rocha, G. Garcia-effron, S. Park, and D. Perlin, A Ser678Pro Substitution in Fks1p Confers Resistance to Echinocandin Drugs in Aspergillus fumigatus, Antimicrobial Agents and Chemotherapy, vol.51, issue.11, pp.4174-4180, 2007.
DOI : 10.1128/AAC.00917-07

K. Mortensen, E. Mellado, C. Lass-flörl, J. Rodriguez-tudela, H. Johansen et al., Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain, Antimicrobial Agents and Chemotherapy, vol.54, issue.11, pp.4545-4554, 2010.
DOI : 10.1128/AAC.00692-10

A. Hamprecht, D. Buchheidt, J. Vehreschild, O. Cornely, B. Spiess et al., Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany, Euro Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull, vol.17, issue.36, p.20262, 2012.